PRKCD and neoplasm: Finally, IF for arginase—a marker of immunosuppressive macrophages—showed that AAV-Prkcd significantly reduced the proportion of IBA1+/arginase+ cells (Figures 6H and 6I), indicating a shift toward an anti-tumor microglia phenotype.